Galapagos NV
GLPG
#4563
Rank
A$3.17 B
Marketcap
A$47.56
Share price
-0.57%
Change (1 day)
13.82%
Change (1 year)

Galapagos NV (GLPG) - Cash on Hand

Cash on Hand as of September 2025 : A$5.38 Billion

According to Galapagos NV's latest financial reports the company has A$5.38 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galapagos NV - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$5.21 B-12.76%
2023-12-31A$5.97 B-7.36%
2022-12-31A$6.45 B-12.16%
2021-12-31A$7.34 B-11.02%
2020-12-31A$8.25 B-10.74%
2019-12-31A$9.24 B341.26%
2018-12-31A$2.09 B18.47%
2017-12-31A$1.76 B24.58%
2016-12-31A$1.42 B178.04%
2015-12-31A$0.51 B83.1%
2014-12-31A$0.27 B30.4%
2013-12-31A$0.21 B77.57%
2012-12-31A$0.12 B192.18%
2011-12-31A$41.23 M-22.05%
2010-12-31A$52.89 M-30.01%
2009-12-31A$75.58 M39.64%
2008-12-31A$54.12 M-34.25%
2007-12-31A$82.32 M-4.53%
2006-12-31A$86.23 M125.54%
2005-12-31A$38.23 M112.3%
2004-12-31A$18 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
A$12.31 B 128.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$27.94 B 418.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$15.73 B 191.99%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
A$8.53 B 58.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
A$0.11 B-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.64 B 116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.31 B-38.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
A$6.69 B 24.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$27.42 B 408.83%๐Ÿ‡บ๐Ÿ‡ธ USA